University of Pennsylvania

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1740-11-14

Employees: 5K

Market Cap: -

Website: http://www.upenn.edu

Clinical Trials

Nurtured in Nature

Not Applicable

Completed

Conditions: Environmental Exposure
Postpartum Depression
Pregnancy Related

Interventions: Behavioral: Nature Coach Intervention

First Posted Date: 2019-10-31

Last Posted Date: 2020-11-24

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 36

Registration Number: NCT04146025

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Postoperative Virtual Clinical Encounters

Not Applicable

Completed

Conditions: Pelvic Organ Prolapse

Interventions: Other: VCE
Other: Survey

First Posted Date: 2019-10-25

Last Posted Date: 2020-08-24

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 54

Registration Number: NCT04138810

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Randomized Clinical Trial to Increase Physical Activity After a a Hypertensive Pregnancy

Not Applicable

Completed

Conditions: Hypertension in Pregnancy
Preeclampsia
Gestational Hypertension

Interventions: Behavioral: Social incentives-based program

First Posted Date: 2019-10-08

Last Posted Date: 2020-12-14

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 128

Registration Number: NCT04119232

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Autoimmunity After Checkpoint Blockade

Recruiting

Conditions: Immunotoxicity
Autoimmunity
Oncology
Cancer

First Posted Date: 2019-10-08

Last Posted Date: 2024-02-14

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 300

Registration Number: NCT04119713

Locations: 🇺🇸
University of Pennsylvania - Abramson Cancer Center, Philadelphia, Pennsylvania, United States

Antibiotic Adherence Practices in Dermatologic Surgery

Completed

Conditions: Medication Adherence

First Posted Date: 2019-10-07

Last Posted Date: 2021-08-30

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 276

Registration Number: NCT04117724

Locations: 🇺🇸
Indiana University, Indianapolis, Indiana, United States
🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States
🇺🇸
University of Missouri Health Care, Columbia, Missouri, United States

and more 6 locations

Mohs Micrographic Surgery and Reconstruction in the Optum Insurance Claims Database

Withdrawn

Conditions: Interpolated Flap Repair
Mohs Micrographic Surgery
Skin Cancer

First Posted Date: 2019-10-07

Last Posted Date: 2020-03-06

Lead Sponsor: University of Pennsylvania

Registration Number: NCT04117373

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Developing Oral LT3 Therapy for Heart Failure - HFrEF

Phase 1

Completed

Conditions: Heart Failure With Reduced Ejection Fraction (HFrEF)
Low T3 Syndrome

Interventions: Drug: Liothyronine
Other: Placebo

First Posted Date: 2019-10-02

Last Posted Date: 2024-12-24

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 28

Registration Number: NCT04112316

Locations: 🇺🇸
PennMedicine, Philadelphia, Pennsylvania, United States

Developing Oral LT3 Therapy for Heart Failure - HFpEF

Phase 1

Completed

Conditions: Low Triiodothyronine Syndrome
Heart Failure With Preserved Ejection Fraction

Interventions: Drug: liothyronine
Other: Placebo

First Posted Date: 2019-10-01

Last Posted Date: 2025-01-08

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 28

Registration Number: NCT04111536

Locations: 🇺🇸
Penn Medicine, Philadelphia, Pennsylvania, United States

Lactation Achievement With Texts at Home

Not Applicable

Completed

Conditions: Breastfeeding
Postpartum Depression
Breastfeeding, Exclusive

Interventions: Behavioral: Text-Based Support

First Posted Date: 2019-09-30

Last Posted Date: 2021-09-02

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 124

Registration Number: NCT04108533

Locations: 🇺🇸
Hospital of the University Of Pennsylvania, Philadelphia, Pennsylvania, United States

Molecular Imaging of the Underlying Mechanism of Cardiotoxicity in Patients With Light Chain Amyloidosis Using PET/CT

Early Phase 1

Terminated

Conditions: Cardiac Amyloidosis

Interventions: Drug: FNOS
Drug: Florbetaben

First Posted Date: 2019-09-26

Last Posted Date: 2024-11-12

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 3

Registration Number: NCT04105634

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy